Now, there is a lack of large-scale, long-term clinical trials evaluating its safety parameters and productivity in humans for this specific indication
Clinical Evidence: GI Interactions SURMOUNT-1 showed 31% nausea rates with tirzepatide, peaking during dose escalations when gastric sensitivity is highest
Occured site reactions, such as redness or swelling, are typically mild, but if they persist, consult with your healthcare provider
Biomimetic nanozyme-decorated hydrogels with H 2 O 2 -activated oxygenation for modulating immune microenvironment in diabetic wound
Life Sci (1997) 61(8):77785
A cornerstone of our practice is to take all of the time necessary with each patient, never rushing through any consultation